Nuclear Medicine and Biology
Volume 35, Issue 1 , Pages 61-66 , January 2008

Preparation and first evaluation of [18F]FE@SUPPY: a new PET tracer for the adenosine A3 receptor

  • Wolfgang Wadsak

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • Department of Inorganic Chemistry, University of Vienna, A-1090 Vienna, Austria
    • ,
  • Leonhard-Key Mien

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, A-1090 Vienna, Austria
    • Department of Psychiatry and Psychotherapy, Medical University of Vienna, A-1090 Vienna, Austria
    • ,
  • Karem Shanab

      Affiliations

    • Department of Drug and Natural Product Synthesis, Faculty of Life Sciences, University of Vienna, A-1090 Vienna, Austria
    • ,
  • Dagmar E. Ettlinger

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • ,
  • Daniela Haeusler

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, A-1090 Vienna, Austria
    • ,
  • Karoline Sindelar

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • ,
  • Rupert R. Lanzenberger

      Affiliations

    • Department of Psychiatry and Psychotherapy, Medical University of Vienna, A-1090 Vienna, Austria
    • ,
  • Helmut Spreitzer

      Affiliations

    • Department of Drug and Natural Product Synthesis, Faculty of Life Sciences, University of Vienna, A-1090 Vienna, Austria
    • ,
  • Helmut Viernstein

      Affiliations

    • Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, A-1090 Vienna, Austria
    • ,
  • Bernhard K. Keppler

      Affiliations

    • Department of Inorganic Chemistry, University of Vienna, A-1090 Vienna, Austria
    • ,
  • Robert Dudczak

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • ,
  • Kurt Kletter

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • ,
  • Markus Mitterhauser

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, A-1090 Vienna, Austria
    • Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, A-1090 Vienna, Austria
    • Hospital Pharmacy of the General Hospital of Vienna, A-1090 Vienna, Austria
    • Corresponding Author InformationCorresponding author. Department of Nuclear Medicine, AKH Wien, Waehringer Guertel 18–20, A-1090 Vienna, Austria. Tel.: +43 1 40400 1557; fax: +43 1 40400 1559.

Received 13 August 2007 ,Revised 11 September 2007 ,Accepted 27 September 2007.

References 

  1. Baraldi PG, Cacciari B, Romagnoli R, Merighi S, Varani K, Borea PA, et al. A3 adenosine receptor ligands: history and perspectives. Med Res Rev. 2000;20:103–128
  2. Merighi S, Varani K, Gessi S, Cattabriga E, Iannotta V, Ulouglu C, et al. Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375. Br J Pharmacol. 2001;134:1215–1226
  3. Suh BC, Kim TD, Lee JU, Seong JK, Kim KT. Pharmacological characterization of adenosine receptors in PGT-beta mouse pineal gland tumour cells. Br J Pharmacol. 2001;134:132–142
  4. Gessi S, Varani K, Merighi S, Cattabriga E, Iannotta V, Leung E, et al. A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study. Mol Pharmacol. 2002;61:415–424
  5. Fishman P, Bar-Yehuda S, Madi L, Cohn I. A3 adenosine receptor as a target for cancer therapy. Anticancer Drugs. 2002;13:1–8
  6. Fishman P, Bar-Yehuda S, Ardon E, Rath-Wolfson L, Barrer F, Ochaion A, et al. Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist. Anticancer Res. 2003;23:2077–2083
  7. Madi L, Ochaion A, Rath-Wolfson L, Erlanger A, Ohana G, Harish A, et al. The A3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition. Clin Cancer Res. 2004;10:4472–4479
  8. Liang BT, Jacobson KA. A physiological role of the adenosine A3 receptor: sustained cardioprotection. Proc Natl Acad Sci U S A. 1998;95:6995–6999
  9. von Lubitz DK, Ye W, McClellan J, Lin RCS. Stimulation of adenosine A3 receptors in cerebral ischemia. Neuronal death, recovery, or both?. Ann N Y Acad Sci. 1999;890:93–106
  10. Avila MY, Stone RA, Civan MM. Knockout of A3 adenosine receptors reduces mouse intraocular pressure. Invest Ophthalmol Vis Sci. 2002;43:3021–3026
  11. von Lubitz DK, Simpson KL, Lin RC. Right thing at a wrong time? Adenosine A3 receptors and cerebroprotection in stroke. Ann N Y Acad Sci. 2001;939:85–96
  12. Laudadio MA, Psarrapoulou C. The A3 receptor agonist 2-Cl-IB-MECA facilitates epileptiform discharges in the CA3 area of immature rat hippocampal slices. Epilepsy Res. 2004;59:83–94
  13. Li AH, Moro S, Forsyth N, Melman N, Ji XD, Jacobson KA. Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists. J Med Chem. 1999;42:706–721
  14. Lopes LV, Rebola N, Pinheiro PC, Richardson PJ, Oliveira CR, Cunha RA. Adenosine A3 receptors are located in neurons of the rat hippocampus. NeuroReport. 2003;26:1645–1648
  15. Okada M, Kawata Y, Kiryu K, Mizuno K, Wada K, Tasaki H, et al. Effects of adenosine receptor subtypes on hippocampal extracellular serotonin level and serotonin reuptake activity. J Neurochem. 1997;69:2581–2588
  16. Zhu CB, Hewlett WA, Feoktistov I, Biaggioni I, Blakely RD. Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation. Mol Pharmacol. 2004;65:1462–1474
  17. Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G, Wasserman W. Structure and function of adenosine receptors and their genes. Naunyn–Schmiedeberg's Arch Pharmacol. 2000;362:364–374
  18. Jenner TL, Mellick AS, Harrison GJ, Griffiths LR, Rose'Meyer RB. Age-related changes in cardiac adenosine receptor expression. Mech Ageing Dev. 2004;125:211–217
  19. Ettlinger DE, Wadsak W, Mien L-K, Machek M, Wabnegger L, Rendl G, et al. The metabolic profile of [18F]FETO. Eur J Nucl Med Mol Imaging. 2006;33:928–931
  20. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 4th ed.. San Diego: Academic Press; 1998;

PII: S0969-8051(07)00243-0

doi: 10.1016/j.nucmedbio.2007.09.004

Nuclear Medicine and Biology
Volume 35, Issue 1 , Pages 61-66 , January 2008

Article Tools

* Image Usage & Resolution